Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02012231
Title Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Plexxikon
Indications

thyroid gland cancer

melanoma

Advanced Solid Tumor

hairy cell leukemia

Therapies

PLX8394

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Scottsdale Healthcare Scottsdale Arizona 85258 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Evergreen Hematology & Oncology Spokane Washington 99218 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field